In Resectable EGFR-mutant NSCLC, the Path Forward Isn’t Always Straightforward - IASLC

In Resectable EGFR-mutant NSCLC, the Path Forward Isn’t Always Straightforward – IASLC

International Association for the Study of Lung Cancer shared a post on LinkedIn:

“In resectable EGFR-mutant NSCLC, the path forward isn’t always straightforward.

In the latest episode of Lung Cancer Considered, Dr. Stephen Liu moderates a Virtual Tumor Board case with Drs. Chunxia Su and Collin Blakely. Together, they explore how to approach diagnosis, multidisciplinary planning, and treatment strategies for this unique patient population.

Listen now!”

Read More About Non-Small Cell Lung Cancer on OncoDaily’s Article.

NSCLC Lung cancer

cancer Chunxia Su Collin Blakely Lung cancer Lung Cancer Considered NSCLC OncoDaily Oncology Resectable EGFR-mutant NSCLC Stephen V Liu